» Articles » PMID: 30326861

Ischemic Stroke As a Complication of Cryptococcal Meningitis and Immune Reconstitution Inflammatory Syndrome: a Case Report

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2018 Oct 18
PMID 30326861
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cryptococcal meningitis remains the leading cause of adult meningitis in Sub-Saharan Africa. Immune Reconstitution Inflammatory Syndrome (IRIS) following anti-retroviral therapy (ART) initiation is an important complication. Here we report the first documented case of a IRIS reaction presenting as an ischemic stroke.

Case Presentation: A 38 year old newly diagnosed HIV-infected, ART naive Malawian male presented to a tertiary referral hospital in Blantyre, Malawi with a 2 week history of headache. A diagnosis of cryptococcal meningitis was made and the patient was started on 1200 mg fluconazole once daily and flucytosine 25 mg/kg four times daily as part of the Advancing Cryptococcal Treatment for Africa (ACTA) clinical trial. There was an initial clinical and microbiological response to anti-fungal treatment and anti-retroviral therapy was started at week 4. The patient re-presented 16 days later with recurrence of headache, fever, and a sudden onset of left sided weakness in the context of rapid immune reconstitution; peripheral CD4 count had increased from a baseline of 29 cells/μl to 198 cells/μl. Recurrence of cryptococcal meningitis was excluded through CSF examination and fungal culture. Magnetic Resonance Imaging (MRI) of the brain demonstrated multi-focal DWI (diffusion weighted imaging) positive lesions consistent with an ischemic stroke. Given the temporal relationship to ART initiation, these MRI findings in the context of sterile CSF with raised CSF protein and a rapid immune reconstitution, following an earlier favorable response to treatment is most consistent with a paradoxical Immune Reconstitution Inflammatory Syndrome.

Conclusions: Stroke is an increasing cause of morbidity and mortality amongst HIV infected persons. Ischemic stroke is a recognized complication of cryptococcal meningitis in the acute phase and is thought to be mediated by an infectious vasculitis. This is the first time an ischemic stroke has been described as part of a paradoxical IRIS reaction. This report adds to the spectrum of clinical IRIS presentations recognized and highlights to clinicians the potential complications encountered at ART initiation in severely immunocompromised patients.

Citing Articles

Novel Insight into the Modulatory Effect of Traditional Chinese Medicine on Cerebral Ischemia-Reperfusion Injury by Targeting Gut Microbiota: A Review.

Ren Y, Chen G, Hong Y, Wang Q, Lan B, Huang Z Drug Des Devel Ther. 2025; 19():185-200.

PMID: 39810832 PMC: 11731027. DOI: 10.2147/DDDT.S500505.


The State of Stroke Research in Malawi: Results from a Mapping Review Study.

Mtambo M, Masangwi D, Soko A, Kaledzera T, Bickton F, Chipeta M J Multidiscip Healthc. 2024; 17:4023-4041.

PMID: 39175495 PMC: 11339346. DOI: 10.2147/JMDH.S476012.


Management and outcome of intracranial fungal infections in children and adults in Africa: a scoping review.

Takoutsing B, Ooi S, Egu C, Gillespie C, Dalle D, Erhabor J BMC Infect Dis. 2024; 24(1):789.

PMID: 39107727 PMC: 11301832. DOI: 10.1186/s12879-024-09694-2.


Intersecting Pathways: The Role of Metabolic Dysregulation, Gastrointestinal Microbiome, and Inflammation in Acute Ischemic Stroke Pathogenesis and Outcomes.

Nuszkiewicz J, Kukulska-Pawluczuk B, Piec K, Jarek D, Motolko K, Szewczyk-Golec K J Clin Med. 2024; 13(14).

PMID: 39064298 PMC: 11278353. DOI: 10.3390/jcm13144258.


Reframing the clinical phenotype and management of cryptococcal meningitis.

Rocha M, Bain H, Stone N, Meya D, Darie L, Toma A Pract Neurol. 2024; 25(1):25-39.

PMID: 38997136 PMC: 11877062. DOI: 10.1136/pn-2024-004133.


References
1.
Martin-Blondel G, Delobel P, Blancher A, Massip P, Marchou B, Liblau R . Pathogenesis of the immune reconstitution inflammatory syndrome affecting the central nervous system in patients infected with HIV. Brain. 2011; 134(Pt 4):928-46. DOI: 10.1093/brain/awq365. View

2.
Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A . High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008; 47(1):123-30. DOI: 10.1086/588792. View

3.
Cinti S, Armstrong W, Kauffman C . Case report. Recurrence of increased intracranial pressure with antiretroviral therapy in an AIDS patient with cryptococcal meningitis. Mycoses. 2002; 44(11-12):497-501. DOI: 10.1046/j.1439-0507.2001.00663.x. View

4.
Werner A, Vuong L, Hedges T, Baumal C . IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME CAUSING PROGRESSIVE OPTIC NERVE EDEMA IN CRYPTOCOCCAL MENINGITIS. Retin Cases Brief Rep. 2017; 13(3):207-210. DOI: 10.1097/ICB.0000000000000582. View

5.
Jarvis J, Bicanic T, Loyse A, Namarika D, Jackson A, Nussbaum J . Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes. Clin Infect Dis. 2013; 58(5):736-45. PMC: 3922213. DOI: 10.1093/cid/cit794. View